SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-048533
Filing Date
2018-08-01
Accepted
2018-08-01 06:03:34
Documents
68
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-14085_110q.htm 10-Q 1466461
2 EX-31.1 a18-14085_1ex31d1.htm EX-31.1 14408
3 EX-31.2 a18-14085_1ex31d2.htm EX-31.2 14374
4 EX-32.1 a18-14085_1ex32d1.htm EX-32.1 8396
5 EX-32.2 a18-14085_1ex32d2.htm EX-32.2 8392
  Complete submission text file 0001104659-18-048533.txt   7257285

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT uthr-20180630.xml EX-101.INS 1800554
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20180630.xsd EX-101.SCH 55660
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20180630_cal.xml EX-101.CAL 57160
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20180630_def.xml EX-101.DEF 229457
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT uthr-20180630_lab.xml EX-101.LAB 518373
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20180630_pre.xml EX-101.PRE 376132
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 18982873
SIC: 2834 Pharmaceutical Preparations